Posted on February 14, 2013
A new study describes the pattern of risk for one form of cancer, acute myeloid leukemia (AML), that has risen over the past three decades for adults who have previously been treated with chemotherapy for other forms of cancer, notably non-Hodgkin lymphoma. The findings, from researchers at the National Cancer Institute (NCI), part of NIH, and colleagues, appeared online in Blood on Feb.14, 2013.
The National Cancer Institute (NCI) press release for the study
To request an interview with a DCEG investigator, contact the NCI Office of Media Relations:
E-mail:
ncipressofficers@mail.nih.gov
Phone: 301-496-6641